Premier League relegation battle: Spurs and West Ham wins mean Leeds and Nottingham Forest still have work to do - Sky Sports

Why Revolution Medicines (RVMD) Is Up 6.2% After Early Zoldonrasib Pancreatic Cancer Data And What's Next – Yahoo Finance

July 4, 2026

Why Revolution Medicines (RVMD) Is Up 6.2% After Early Zoldonrasib Pancreatic Cancer Data And What’s Next Yahoo FinanceRevolution adds two new readouts to RAS(ON) momentum in pancreatic cancer FirstWord PharmaRevolution Medicines shares promising data around KRAS drug combination Endpoints NewsAnirban Maitra։ Data on Zoldonrasib Plus Daraxonrasib in 2nd and 3rd Line Metastatic Pancreatic Cancer OncodailyZoldonrasib Combos, Including With Daraxonrasib, Yield High Response Rates in PDAC Targeted Oncology